1Neuromodulation Center and Center for Clinical Research Learning,Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, 2Physical Therapy Department,Federal University of Sao Carlos, 3Vicerrectorado de Investigación,Universidad de Investigación para la Generación y Síntesis de Evidencia en Salud, Universidad San Ignacio de Loyola, 4Department of Medical Sciences, Graduate School of Medicine,Korea University, 5Neurive Co., Ltd., 6Department of Otorhinolaryngology-Head and Neck Surgery,Korea University Medical Center
该协议提供了有关如何在临床试验中应用经皮耳迷走神经刺激 （taVNS） 的信息，包括潜在的生物标志物，例如 EEG 指标和心率变异性 （HRV） 以衡量这种治疗对自主神经系统的影响。
